大型抑郁症和中风后情绪障碍背后的分子机制
Daniela Colita1, Daiana Burdusel2, Daniela Glavan2
1Doctoral School, University of Medicine and Pharmacy Carol Davila, 050474 Bucharest, Romania.
Journal of affective disorders
|October 12, 2023
概括
大型抑郁症 (MDD) 和中风后抑郁症 (PSD) 分享生物途径,但在发病和进展方面有所不同. 了解这些情绪障碍对于有效的治疗策略至关重要.
科学领域:
- 神经科学和精神病学 在
- 临床心理学 临床心理学
- 医学研究 医学研究
背景情况:
- 重度抑郁症 (MDD) 和中风后抑郁症 (PSD) 是普遍存在的,使人衰弱的心理健康状况.
- 这两种情况都与关键神经递质通路的干扰有关,包括单氨基,谷氨基和GABA基系统.
- 诸如荷尔蒙,免疫,衰老,细胞,分子和表观遗传影响等因素有助于情绪障碍.
研究的目的:
- 审查MDD和PSD背后的共同和独特的生物机制.
- 探索中风病变位置对PSD发展的影响.
- 为这些情绪障碍提供当前治疗方式的概述.
主要方法:
- 关于主要抑郁症和中风后抑郁症现有研究的文献综述.
- 分析共同和不同的病因因素和神经生物学途径.
- 对MDD和PSD的发病,进展和临床特征进行比较.
主要成果:
- MDD和PSD在破坏单氨基基途径方面有共同点.
- 脑卒中损伤位置是PSD的主要决定因素,影响各种神经递质系统.
- 脑卒中后的PSD表现出快速发作,可能自发消失,但与MDD的逐渐发作相比,PSD的死亡风险更高.
结论:
- 尽管有共同的生物学基础,但MDD和PSD存在着不同的临床轨迹和病因因素.
- 中风病变的位置显著影响中风后抑郁症的表现和严重程度.
- 对多模式治疗方法的进一步研究对于有效管理这些复杂情绪障碍至关重要.
更多相关视频
04:38A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
Published on: May 22, 2019
10.3K
06:55An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
22.5K
相关概念视频
Depressive Disorders: Etiology
107
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
107
Depression: Overview
259
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
259
Antidepressant Drugs: MAOIs and Other Agents
256
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
256
Long-term Depression
30.9K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
30.9K
Antidepressant Drugs: Overview
527
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
527
Depressive Disorders: MDD and Dysthymia
142
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
142
